About Stark Pharma Private Limited
Data last updated:
Stark Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the HR outsourcing and talent management segment of the business process outsourcing sector. It was incorporated on 26 December 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U72900TG2014PTC097007. Its GSTIN is 36AAVCS5028G1ZY (Telangana).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.52 Cr. It was formerly known as Stark Pharma Soft Tech Private Limited. It is led by directors including Teja Sravanthi Darapureddy and Parvataneni Ramamohana Rao.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.43 Cr, a decline of 30% compared to the previous year. For the same year it recorded a net loss of ₹61.72 Lakh (net margin -43.2%) and EBITDA of -₹56.65 Lakh (EBITDA margin -39.6%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website starkpharma.com.
Company details
Contact details
Stark Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is starkpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressUnit 512 5th Floor Manjeera Majestic Commercial Jntu Hitec, Hcity Road, Hyderabad, Telangana, India – 500072
- IndustryBusiness Outsourcing, HR Outsourcing & Talent Management
To see the full contact details of Stark Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Stark Pharma is information and communication. In detail, this covers computer programming, consultancy and related activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| J | Information and communication | 62 | Computer programming, consultancy and related activities |
To see the full business activity and turnover split of Stark Pharma Private Limited, buy the company report.
Financials of Stark Pharma Private Limited
FY 2024 filings availableStark Pharma Private Limited reported revenue of ₹1.43 Cr (down 30% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 6% over three years, including a 30% fall in the latest year. EBITDA fell 320% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹56.65 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹61.72 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -39.6% | ||||
| Net Profit Margin | -43.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stark Pharma Private Limited, buy the company report.
Board of directors of Stark Pharma Private Limited
Stark Pharma has 5 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Teja Sravanthi Darapureddy | Director | 19 Apr 2024 | 2 Years 6 Months | Current |
| Parvataneni Ramamohana Rao | Director | 01 Dec 2018 | 7 Years 10 Months | Current |
| Madhukiran Parvathaneni Also directs: Arni Medica Private Limited | Director | 18 Jul 2025 | 1 Years 3 Months | Current |
| Prathipati Kalyani | Director | 17 Mar 2023 | 3 Years 7 Months | Current |
| Venkateswararao Parvathaneni | Director | 26 Apr 2025 | 1 Years 6 Months | Current |
Auditor
Stark Pharma Private Limited is audited by N S REDDY & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N S REDDY & ASSOCIATES | FY 2023 | 245884 |
Shareholding
The shareholding of Stark Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Stark Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Stark Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stark Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Stark Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAVCS5028G1ZY | Telangana | Active | 05 Dec 2017 |
To see the full GST registrations and return filing status of Stark Pharma Private Limited, buy the company report.
Recent activity
Stark Pharma Private Limited has 12 board changes on record since 2018: 5 appointments and 7 cessations. The latest: Madhukiran Parvathaneni was appointed as Director on 18 Jul 2025.
3 earlier events are in the company report.
Frequently asked questions
Stark Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in HR outsourcing and talent management, within the business outsourcing industry. It was incorporated on 26 December 2014 (12+ years old) and is registered under CIN U72900TG2014PTC097007.
Stark Pharma has 5 current directors:
- Teja Sravanthi Darapureddy - Director
- Parvataneni Ramamohana Rao - Director
- Madhukiran Parvathaneni - Director
- Prathipati Kalyani - Director
- Venkateswararao Parvathaneni - Director
The latest financial statements of Stark Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Stark Pharma is 36AAVCS5028G1ZY, registered in Telangana.
The CIN (Corporate Identification Number) of Stark Pharma is U72900TG2014PTC097007. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stark Pharma was incorporated on 26 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
Madhukiran Parvathaneni was appointed as Director on 18 Jul 2025. Venkateswararao Parvathaneni was appointed as Director on 26 Apr 2025. Teja Sravanthi Darapureddy was appointed as Director on 19 Apr 2024. Stark Pharma has 12 board changes on record in total.
Stark Pharma can be reached through the website starkpharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Stark Pharma is at Unit 512 5th Floor Manjeera Majestic Commercial Jntu Hitec, Hcity Road, Hyderabad, Telangana, India – 500072.
Stark Pharma operates in the business outsourcing industry, in the HR outsourcing and talent management segment.